Leadership Development Training Courses for the Office of Translational Sciences (OTS) Staff
Closed Special Notice Posted
- Solicitation number
- 75F40123R00120
- Agency
-
Office of Operations
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541 Professional, Scientific, and Technical Services
- Place of performance
- Silver Spring, Maryland 20993, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The US Food and Drug Administration (FDA) intends to issue a single award to provide OTS professionals with training, exercises, and activities to improve the quality of their work products. The services will be provided at the FDA's office in Silver Spring, MD. Interested parties are invited to express their interest and capabilities by August 11, 2023.
Services to be provided by the contractor:
- Professional training for OTS staff
- Organizing exercises for OTS staff
- Organizing activities for OTS staff
- Improving the quality of work products of OTS staff
- Any other related services as required by the FDA.
Notice text
This announcement is not a Request for Proposal.
The US Food and Drug Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to issue a single award to from a fair opportunity competition, amongst current incumbent IDIQ contract holders; to provide - OTS professionals with training, exercises, and activities, that will help to improve the quality of their work products; at
The US Food and Drug Administration 10903 New Hampshire Avenue Building 66 Silver Spring MD 20993.
The propose simplified acquisition is for services; the Government intends to solicit and negotiate to identified source only. Interested parties may identify their interests and capabilities to respond to the requirement within seven (7) days after the publication of this notice. A determination by the Government not to compete this proposed simplified acquisition based upon responses to this notice, is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive requirement. No further solicitation is available.
FDA will consider all responses received prior to the closing date of this notice and will use responses in determining, whether it is necessary to use full and open competition for this requirement. Responses shall be emailed to Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, by August,11, 2023, 12:00 PM EST.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| FDA Scientific & Regulatory Support Services(SRS) | FDA Office of Acquisition and Grant Services | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity